Literature DB >> 24745888

Posterior reversible encephalopathy syndrome.

Jeffrey B Rykken1, Alexander M McKinney2.   

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a complex disorder, our understanding of which continues to evolve. PRES has many clinical associations, many causative factors, a variety of imaging manifestations, and its pathophysiology remains a topic of debate. There are also many other disorders that may mimic PRES. We present a concise review of PRES to enable the radiologist to more readily and easily recognize this treatable disorder with important clinical implications.
© 2013 Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2014        PMID: 24745888     DOI: 10.1053/j.sult.2013.09.007

Source DB:  PubMed          Journal:  Semin Ultrasound CT MR        ISSN: 0887-2171            Impact factor:   1.875


  19 in total

1.  A study on clinical characteristics and the causes of missed diagnosis of reversible posterior leukoencephalopathy syndrome in eclampsia.

Authors:  Tong Shen; Hao Chen; Jia Jing; Hafiz Khuram Raza; Zuozhui Zhang; Lei Bao; Su Zhou; Shenyang Zhang; Guiyun Cui
Journal:  Neurol Sci       Date:  2019-05-07       Impact factor: 3.307

Review 2.  Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications.

Authors:  Melinda Liu; Yuan Yu M Huang; Sylvia Hsu; Joseph S Kass
Journal:  CNS Drugs       Date:  2016-12       Impact factor: 5.749

Review 3.  Anti-Angiogenic Tyrosine Kinase Inhibitors and Reversible Posterior Leukoencephalopathy Syndrome: Could Hypomagnesaemia Be the Trigger?

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2017-05       Impact factor: 5.606

Review 4.  Stroke-like migraine attacks after radiation therapy (SMART) syndrome-a case series and review.

Authors:  Urvish K Patel; Khush Patel; Preeti Malik; Ahmed Elkady; Nidhi Patel; Abhishek Lunagariya
Journal:  Neurol Sci       Date:  2022-07-13       Impact factor: 3.307

Review 5.  CNS Infections in Immunoincompetent Patients : Neuroradiological and Clinical Features.

Authors:  Stefan Weidauer; Marlies Wagner; Simon Jonas Enkirch; Elke Hattingen
Journal:  Clin Neuroradiol       Date:  2019-09-19       Impact factor: 3.649

6.  Cytotoxic Edema in Posterior Reversible Encephalopathy Syndrome: Correlation of MRI Features with Serum Albumin Levels.

Authors:  B Gao; B X Yu; R S Li; G Zhang; H Z Xie; F L Liu; C Lv
Journal:  AJNR Am J Neuroradiol       Date:  2015-07-02       Impact factor: 3.825

7.  Clinical Utility of Computed Tomography and Magnetic Resonance Imaging for Diagnosis of Posterior Reversible Encephalopathy Syndrome after Stem Cell Transplantation in Children and Adolescents.

Authors:  Christopher E Dandoy; Luke L Linscott; Stella M Davies; James L Leach; Kasiani C Myers; Javier El-Bietar; Ranjit S Chima; Abigail Pate; Adam Nelson; Gregory Wallace; Hector R Wong; Sonata Jodele
Journal:  Biol Blood Marrow Transplant       Date:  2015-07-27       Impact factor: 5.742

8.  Utility and Significance of Gadolinium-Based Contrast Enhancement in Posterior Reversible Encephalopathy Syndrome.

Authors:  S J Karia; J B Rykken; Z J McKinney; L Zhang; A M McKinney
Journal:  AJNR Am J Neuroradiol       Date:  2015-11-12       Impact factor: 3.825

9.  Tumour-like presentation of atypical posterior reversible encephalopathy syndrome with prominent brainstem involvement.

Authors:  Vincenzo Di Stefano; Marianna Gabriella Rispoli; Marco Onofrj; Maria Vittoria De Angelis
Journal:  BMJ Case Rep       Date:  2020-01-08

10.  A case of posterior reversible encephalopathy syndrome associated with gilenya(®) (fingolimod) treatment for multiple sclerosis.

Authors:  Hans Lindå; Anders von Heijne
Journal:  Front Neurol       Date:  2015-03-04       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.